Deric D. Schoof

1.0k total citations
34 papers, 866 citations indexed

About

Deric D. Schoof is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Deric D. Schoof has authored 34 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 19 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Deric D. Schoof's work include Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Deric D. Schoof is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Deric D. Schoof collaborates with scholars based in United States, Australia and United Kingdom. Deric D. Schoof's co-authors include Timothy J. Eberlein, George E. Peoples, P S Goedegebuure, Anthony F. Massaro, John Andrews, T.J. Eberlein, Walter J. Urba, Peter S. Goedegebuure, Sung Eun Jung and Susan M. Pond and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Deric D. Schoof

33 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deric D. Schoof United States 17 618 406 221 96 72 34 866
T Tuypens United States 7 601 1.0× 185 0.5× 168 0.8× 128 1.3× 52 0.7× 8 867
Avi Eisenthal Israel 17 558 0.9× 241 0.6× 237 1.1× 138 1.4× 49 0.7× 53 846
Martin H. Goldrosen United States 16 283 0.5× 272 0.7× 160 0.7× 99 1.0× 43 0.6× 53 626
Karen Berry United States 9 471 0.8× 175 0.4× 144 0.7× 85 0.9× 71 1.0× 12 755
S Ohzeki Japan 9 396 0.6× 167 0.4× 169 0.8× 58 0.6× 27 0.4× 9 633
Jian‐Guo Chai United Kingdom 21 1.1k 1.7× 257 0.6× 193 0.9× 60 0.6× 60 0.8× 38 1.3k
Linda A. Battiato United States 5 333 0.5× 377 0.9× 161 0.7× 41 0.4× 30 0.4× 6 632
Caroline P. Edwards United States 12 491 0.8× 98 0.2× 189 0.9× 111 1.2× 46 0.6× 18 823
Rodney A. Prell United States 15 1.0k 1.6× 563 1.4× 220 1.0× 143 1.5× 22 0.3× 24 1.3k
Yoshiro Kashii Japan 12 610 1.0× 366 0.9× 235 1.1× 30 0.3× 45 0.6× 22 896

Countries citing papers authored by Deric D. Schoof

Since Specialization
Citations

This map shows the geographic impact of Deric D. Schoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deric D. Schoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deric D. Schoof more than expected).

Fields of papers citing papers by Deric D. Schoof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deric D. Schoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deric D. Schoof. The network helps show where Deric D. Schoof may publish in the future.

Co-authorship network of co-authors of Deric D. Schoof

This figure shows the co-authorship network connecting the top 25 collaborators of Deric D. Schoof. A scholar is included among the top collaborators of Deric D. Schoof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deric D. Schoof. Deric D. Schoof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurt, Robert A., Walter J. Urba, & Deric D. Schoof. (2000). Isolation of genes overexpressed in freshly isolated breast cancer specimens. Breast Cancer Research and Treatment. 59(1). 41–48. 10 indexed citations
2.
Schoof, Deric D., et al.. (1998). Immunization of Metastatic Breast Cancer Patients with CD80-Modified Breast Cancer Cells and GM-CSF. Advances in experimental medicine and biology. 451. 511–518. 15 indexed citations
3.
Goedegebuure, Peter S., et al.. (1995). Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.. Journal of Clinical Oncology. 13(8). 1939–1949. 94 indexed citations
4.
Schoof, Deric D., et al.. (1993). The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitro. International Journal of Cancer. 55(4). 630–635. 23 indexed citations
5.
6.
Molloy, R. G., D. S. Ó’Ríordáin, R. G. Holzheimer, et al.. (1993). Lymphokine Activated Killer Cells Enhance IL-2 Prevention of Sepsis-Related Death in a Murine Model of Thermal Injury. Journal of Surgical Research. 54(6). 565–570. 6 indexed citations
7.
Schoof, Deric D., et al.. (1993). Immunomodulatory Effects of Interleukin-12 on Human Tumor-Infiltrating Lymphocytes. Journal of Immunotherapy. 14(1). 1–10. 32 indexed citations
8.
Schoof, Deric D., et al.. (1992). The biological effects of immunosuppression on cellular immunotherapy. Surgical Oncology. 1(1). 27–35. 8 indexed citations
9.
Schoof, Deric D., et al.. (1992). Secondary cytokine production by lymphoid cells used in cellular immunotherapy. Surgical Oncology. 1(2). 163–172. 6 indexed citations
10.
Winzor, Donald J., Mark R. Bowles, Paul R. Pentel, Deric D. Schoof, & Susan M. Pond. (1991). Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay. Molecular Immunology. 28(9). 995–1001. 6 indexed citations
11.
Moore, Francis D., Deric D. Schoof, Mary L. Rodrick, & Timothy J. Eberlein. (1991). The systemic complement activation caused by interleukin‐2/lymphokine‐activated killer‐cell therapy of cancer causes minimal systemic neutrophil activation. International Journal of Cancer. 49(4). 504–508. 8 indexed citations
12.
Eberlein, Timothy J. & Deric D. Schoof. (1991). The role of interleukin-2 in cancer immunotherapy.. PubMed. 17(1). 49–56. 7 indexed citations
13.
Eberlein, Timothy J., Mary L. Rodrick, Anthony F. Massaro, et al.. (1989). Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans. Cancer Immunology Immunotherapy. 30(3). 145–150. 16 indexed citations
14.
Schoof, Deric D., Sung Eun Jung, & Timothy J. Eberlein. (1989). Human tumor‐infiltrating lymphocyte (TIL) cytotoxicity facilitated by anti‐T‐cell receptor antibody. International Journal of Cancer. 44(2). 219–224. 11 indexed citations
15.
Bowles, Mark R., S. Claiborne Johnston, Deric D. Schoof, Paul R. Pentel, & Susan M. Pond. (1988). Large scale production and purification of paraquat and desipramine monoclonal antibodies and their fab fragments. International Journal of Immunopharmacology. 10(5). 537–545. 29 indexed citations
16.
Schoof, Deric D., et al.. (1988). Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells.. PubMed. 48(17). 5007–10. 73 indexed citations
17.
Pond, Susan M., S. Claiborne Johnston, Deric D. Schoof, et al.. (1987). Repeated Hemoperfusion and Continuous Arteriovenous Hemofiltration in a Paraquat Poisoned patient. Journal of Toxicology Clinical Toxicology. 25(4). 305–316. 11 indexed citations
18.
Schoof, Deric D. & C. H. Tempelis. (1986). The role of soluble protein a in chicken spleen cell activation. Developmental & Comparative Immunology. 10(2). 247–257.
19.
Schoof, Deric D., et al.. (1986). Evaluation of Predator–Prey Relationships Using an Enzyme Immunoassay. Annals of the Entomological Society of America. 79(1). 91–95. 17 indexed citations
20.
Schoof, Deric D. & C. H. Tempelis. (1984). B cell activation in chickens induced by Staphylococcusaureus. Developmental & Comparative Immunology. 8(2). 403–414. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Tuypens Breakdown of academic impact, for papers by Avi Eisenthal Breakdown of academic impact, for papers by Martin H. Goldrosen Breakdown of academic impact, for papers by Karen Berry Breakdown of academic impact, for papers by S Ohzeki Breakdown of academic impact, for papers by Jian‐Guo Chai Breakdown of academic impact, for papers by Linda A. Battiato Breakdown of academic impact, for papers by Caroline P. Edwards Breakdown of academic impact, for papers by Rodney A. Prell Breakdown of academic impact, for papers by Yoshiro Kashii
Rankless by CCL
2026